SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-08-000141
Filing Date
2008-02-14
Accepted
2008-02-14 17:15:44
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 121834
  Complete submission text file 0000898432-08-000141.txt   124060
Mailing Address BC RESEARCH COMPLEX 3650 WESBROOK MALL VANCOUVER A1 V6S2L2
Business Address 1750 609 GRANVILLE ST VANCOUVER B C CANADA A1 00000 (604) 221-9666
MIGENIX Inc. (Subject) CIK: 0000915458 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0430
Type: SC 13G/A | Act: 34 | File No.: 005-78624 | Film No.: 08618843
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice